Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines

被引:12
|
作者
Meesungnoen, J
Jay-Gerin, JP
Mankhetkorn, S [1 ]
机构
[1] Burapha Univ, Fac Sci, Lab Phys Chem Mol & Cellular Biol, Chonburi 20131, Thailand
[2] Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Sherbrooke, PQ J1H 5N4, Canada
关键词
multidrug resistance; P-glycoprotein; pirarubicin; acidic organelles; MDR1 mRNA levels; fluorescence spectroscopy; kinetic parameters;
D O I
10.1139/Y02-132
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this work, we sought to investigate the relation existing between MDR1 mRNA levels, the resistance factor (RF), and the efficiency of efflux of pirarubicin (THP) mediated by P-glycoprotein (P-gp) in multidrug-resistant (MDR) K562 sublines. The MDR K562 sublines were selected from K562/adr cells by exposure to different adriamycin concentrations: 300 nM (K562/300), 1000 nM (K562/1000), and 10 000 nM (K562/10000), yielding RF values of 23.2, 26.5, and 39.6, respectively. The analysis of the P-gp encoding MDR1 gene overexpression by reverse transcriptase - polymerase chain reaction provided evidence of increased MDR1 mRNA levels when the adriamycin concentration used for the MDR cell selection increased. We used spectrofluorometric methods to determine the kinetics of the uptake and P-gp-mediated efflux of THP in the different selected MDR K562 sublines. Our data showed that (i) the maximal rate of P-gp-mediated efflux of THP, V-max, increased with increasing RF; (ii) the observed Michaelis constant, K-m, had the same value for all selected sublines, thus leading to an overall increase in the ratio V-max/K-m (5.1 x 10(-3), 6.2 x 10(-3), 6.8 x 10(-3), and 9.3 x 10(-3) s(-1) for K562/adr, K562/300, K562/1000, and K562/10000 cells, respectively), and (iii) the determination of the Hill coefficient (n(H)) gave values close to 2, which suggested a positive cooperative transport of THP with the expelling of two molecules of THP per turnover of P-gp. This study demonstrated that, in the K562/adr sublines used in our experiments, P-gp played a major role in conferring the MDR phenotype. Moreover, under our experimental conditions, intracellular acidic organelles were shown to contribute to decreased drug-target interaction and, thereby, decreased cytotoxicity. The variation of the concentrations of THP accumulated in the acidic organelles as a function of the total THP concentration added to the cells was the same, within the limits of experimental errors, whatever the degree of resistance of the studied MDR K562 sublines. Finally, this study suggested that, in the selected MDR K562 sublines, the K+/H+ antiporter exchanger could be activated by the pirarubicin transport, leading to a probable acidification of intracellular pH. The P-gp-mediated efflux of THP and an accumulation of THP in acidic organelles confer an advantage for MDR cells in surviving prolonged exposure to cytotoxic agents and giving rise to high degrees of resistance.
引用
收藏
页码:1054 / 1063
页数:10
相关论文
共 37 条
  • [31] Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression
    Pan, Jia
    Miao, Dong
    Chen, Li
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 288 : 32 - 37
  • [32] Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
    Wang, Hong
    Jia, Xiu-Hong
    Chen, Jie-Ru
    Wang, Jian-Yong
    Li, You-Jie
    ONCOLOGY REPORTS, 2016, 35 (06) : 3659 - 3668
  • [33] AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS RESULTS FROM SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE
    CHOI, K
    CHEN, C
    KRIEGLER, M
    RONINSON, IB
    CELL, 1988, 53 (04) : 519 - 529
  • [34] Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance
    Yang, Lingyun
    Li, Ningwei
    Wang, Hongjing
    Jia, Xibiao
    Wang, Xue
    Luo, Juan
    ONCOLOGY REPORTS, 2012, 28 (02) : 592 - 600
  • [35] MULTIDRUG-RESISTANCE GENE (MDR1) RNA LEVELS IN RELATION TO P-GLYCOPROTEIN CONTENT OF LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE-LEUKEMIA
    ALBERTIONI, F
    GRUBER, A
    ARESTROM, I
    VITOLS, S
    MEDICAL ONCOLOGY, 1995, 12 (02): : 79 - 86
  • [36] Dioscin Restores the Activity of the Anticancer Agent Adriamycin in Multidrug-Resistant Human Leukemia K562/Adriamycin Cells by Down-Regulating MDR1 via a Mechanism Involving NF-κB Signaling Inhibition
    Wang, Lijuan
    Meng, Qiang
    Wang, Changyuan
    Liu, Qj
    Peng, Jinyong
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaochi
    Liu, Kexin
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (05): : 909 - 914
  • [37] BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
    Cheung, Chun Hei Antonio
    Lin, Wen-Hsing
    Hsu, John Tsu-An
    Hour, Tzyh-Chyuan
    Yeh, Teng-Kuang
    Ko, Shengkai
    Lien, Tzu-Wen
    Coumar, Mohane Selvaraj
    Liu, Jin-Fen
    Lai, Wen-Yang
    Shiao, Hui-Yi
    Lee, Tian-Ren
    Hsieh, Hsing-Pang
    Chang, Jang-Yang
    PLOS ONE, 2011, 6 (08):